|
?:authorAffiliation
|
-
[\'Department of Pediatrics, Section of Critical Care Medicine, Baylor College of Medicine and Texas Children\'s Hospital, Houston, TX, USA.\', \'Department of Vaccines and Immunity, Medical Research Council the Gambia Unit at the London School of Hygiene and Tropical Medicine, UK.\', \'Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.\', \'Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.\', \'King Edward Memorial Hospital Research Centre, Vadu Rural Health Program Pune, India.\', \'The INCLEN Trust International, New Delhi, India.\', \'National Institute of Public Health, University of Ljubljana, Slovenia.\', \'Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.\', \'CureVac AG, Frankfurt, Germany.\', \'International Vaccine Institute, Seoul, Republic of Korea.\', \'Departments of Pediatrics, Section of Infectious Diseases, and Molecular Virology and Microbiology, Baylor College of Medicine and Texas Children\'s Hospital, Houston, TX, USA.\', \'Department of Pediatrics, Section of Critical Care Medicine, Baylor College of Medicine and Texas Children\'s Hospital, Houston, TX, USA. Electronic address: pxbaster@texaschildrens.org.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}